Picture of Scinai Immunotherapeutics logo

SCNI — Scinai Immunotherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Biondvax Pharmaceuticals Posts Quarterly Loss Per Share $0.005

June 23 (Reuters) - BiondVax Pharmaceuticals Ltd  2F5.F :
    * BIONDVAX ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
    * BIONDVAX PHARMACEUTICALS LTD QUARTERLY LOSS PER SHARE
$0.005

Source text for Eikon:  ID:nPn8blkX7a 
Further company coverage:  2F5.F 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Scinai Immunotherapeutics

See all news